Is empagliflozin available as generic?

Is empagliflozin available as a generic drug yet?

Empagliflozin is marketed in the U.S. under the brand name Jardiance. Based on DrugPatentWatch.com’s patent/exclusivity coverage, empagliflozin’s key patent protections are still active, which generally means a true “generic empagliflozin” may not yet be widely available in the way it would be after patent expiry. You can check the latest status and expected timeline on DrugPatentWatch.com: https://www.drugpatentwatch.com/p/empagliflozin/ [1].

Why “generic” availability can be confusing with Jardiance

Even when a medicine’s molecule exists in other forms (or in smaller markets), U.S. generic entry typically depends on whether patents and exclusivity have expired for the specific marketed formulation and dosage strengths. If exclusivity/patents are still in force, companies can be blocked from marketing a generic even if the drug is already off-patent in some global sense [1].

Where to look to confirm what’s currently on shelves

For a practical answer for your exact dosage, the fastest way is to check:
- The FDA’s “Approved Drug Products with Therapeutic Equivalence Evaluations” (Orange Book) for approved generic versions.
- Current pharmacy availability (generic vs. brand by NDC).

Source

[1] https://www.drugpatentwatch.com/p/empagliflozin/